Bank Of America Corp Abvc Biopharma, Inc. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.62 - $9.1 $31 - $455
50 New
50 $0
Q4 2021

Feb 08, 2022
SELL
$2.15 - $6.03 $1,062 - $2,978
-494 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.03 - $5.1 $1,002 - $2,519
494 New
494 $1,000

About ABVC BIOPHARMA, INC.

ABVC Quotes by TradingView
  • Ticker ABVC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,632,300
  • Market Cap $17M
  • Description
  • ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...
More about ABVC
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email